Top Posts
The Stock Market’s Comeback: Key Takeaways for Investors
S&P 500 Now in Weakest Seasonal Period…Or Is...
Emerging Stocks to Watch – Breakouts, Momentum &...
S&P Global: Mining Sector Sees Mixed Q1, Next...
Coinbase Backs QCAD Stablecoin to Power Canadian Crypto...
Crypto Market Recap: Coinbase Hit by US$400 Million...
Nvidia says it is not sending GPU designs...
Cava revenue beats estimates as Mediterranean chain reports...
Boeing would avoid guilty plea, prosecution over 737...
The S&P 500 Snapped Back Hard: Now What?
  • Home
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Market Commandos
Editor's Pick

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 19, 2025
January 19, 2025

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Stock Futures Lower after S&P 500 futures ticked down 0.18%
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

You may also like

Cava revenue beats estimates as Mediterranean chain reports...

May 17, 2025

Nvidia says it is not sending GPU designs...

May 17, 2025

Boeing would avoid guilty plea, prosecution over 737...

May 17, 2025

‘Shark Tank’ alum Bombas taps former Under Armour...

May 16, 2025

Netflix says its ad tier now has 94...

May 16, 2025

Reddit co-founder Alexis Ohanian takes minority stake in...

May 16, 2025

YouTube will stream NFL Week 1 game in...

May 15, 2025

5 new Uber features you should know —...

May 15, 2025

American Eagle shares plunge 17% after it withdraws...

May 15, 2025

Fintech company Chime files for Nasdaq IPO

May 14, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • The Stock Market’s Comeback: Key Takeaways for Investors

      May 17, 2025
    • S&P 500 Now in Weakest Seasonal Period…Or Is It?

      May 17, 2025
    • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!

      May 17, 2025
    • S&P Global: Mining Sector Sees Mixed Q1, Next Calls for Copper, Battery Metals and M&A

      May 17, 2025
    • Coinbase Backs QCAD Stablecoin to Power Canadian Crypto Adoption

      May 17, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 MarketCommandos.com All Rights Reserved.

    Market Commandos
    • Investing
    • Stock
    • Economy
    • Editor’s Pick